Trial of Overminus Spectacle Therapy for Intermittent Exotropia
NCT: NCT02807350 · COMPLETED
Brief Summary
The main objectives of this randomized trial comparing overminus lens treatment to non-overminus (spectacles without overminus or spectacles with plano lenses) are to determine: * The long-term on-treatment effect of overminus treatment on distance intermittent exotropia (IXT) control score. * The off-treatment effect of overminus treatment on distance IXT control score (following weaning and 3 months off treatment).
Frequently Asked Questions
What is Trial of Overminus Spectacle Therapy for Intermittent Exotropia?
Trial of Overminus Spectacle Therapy for Intermittent Exotropia is a clinical trial registered under NCT02807350. Current status: COMPLETED.
What is the status of NCT02807350?
The current status of NCT02807350 (Trial of Overminus Spectacle Therapy for Intermittent Exotropia) is: COMPLETED.
When did Trial of Overminus Spectacle Therapy for Intermittent Exotropia start?
Trial of Overminus Spectacle Therapy for Intermittent Exotropia started on 2017-01-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.